Annual EBITDA
-$11.47 M
-$9.60 M-512.68%
December 31, 2023
Summary
- As of February 7, 2025, MEDS annual EBITDA is -$11.47 million, with the most recent change of -$9.60 million (-512.68%) on December 31, 2023.
- During the last 3 years, MEDS annual EBITDA has fallen by -$9.07 million (-377.20%).
Performance
MEDS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$3.45 M
-$1.83 M-113.83%
September 30, 2024
Summary
- As of February 7, 2025, MEDS quarterly EBITDA is -$3.45 million, with the most recent change of -$1.83 million (-113.83%) on September 30, 2024.
- Over the past year, MEDS quarterly EBITDA has increased by +$3.08 million (+47.23%).
Performance
MEDS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$21.88 M
-$3.75 M-20.71%
September 30, 2024
Summary
- As of February 7, 2025, MEDS TTM EBITDA is -$21.88 million, with the most recent change of -$3.75 million (-20.71%) on September 30, 2024.
- Over the past year, MEDS TTM EBITDA has dropped by -$3.37 million (-18.21%).
Performance
MEDS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MEDS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -512.7% | +47.2% | -18.2% |
| 3 y3 years | -377.2% | -173.2% | -227.9% |
| 5 y5 years | -10000.0% | -5409.3% | -10000.0% |
MEDS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +512.7% | at low | -1216.2% | +198.8% | +877.4% | at low |
| 5 y | 5-year | +8304.7% | at low | -1216.2% | +198.8% | >+9999.0% | at low |
| alltime | all time | -2672.3% | +148.4% | -943.3% | +726.5% | -5006.8% | +30.3% |
TRxADE HEALTH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.45 M(+113.8%) | -$21.88 M(+20.7%) |
| Jun 2024 | - | -$1.61 M(-75.3%) | -$18.13 M(-2.1%) |
| Mar 2024 | - | -$6.53 M(-36.6%) | -$18.51 M(+42.4%) |
| Dec 2023 | -$11.47 M(+512.7%) | -$10.30 M(-3435.6%) | -$13.01 M(+368.0%) |
| Sep 2023 | - | $308.70 K(-115.5%) | -$2.78 M(-15.7%) |
| Jun 2023 | - | -$1.99 M(+95.2%) | -$3.30 M(+40.0%) |
| Mar 2023 | - | -$1.02 M(+1347.5%) | -$2.35 M(+5.2%) |
| Dec 2022 | -$1.87 M(-63.7%) | -$70.60 K(-66.4%) | -$2.24 M(-23.2%) |
| Sep 2022 | - | -$210.40 K(-80.0%) | -$2.91 M(-26.5%) |
| Jun 2022 | - | -$1.05 M(+16.1%) | -$3.97 M(-27.2%) |
| Mar 2022 | - | -$906.20 K(+21.5%) | -$5.45 M(+5.7%) |
| Dec 2021 | -$5.15 M(+114.4%) | -$746.10 K(-40.8%) | -$5.15 M(-22.8%) |
| Sep 2021 | - | -$1.26 M(-50.3%) | -$6.67 M(+27.0%) |
| Jun 2021 | - | -$2.54 M(+315.1%) | -$5.25 M(+62.7%) |
| Mar 2021 | - | -$610.80 K(-73.1%) | -$3.23 M(+34.3%) |
| Dec 2020 | -$2.40 M(+1661.2%) | -$2.27 M(-1517.9%) | -$2.40 M(+299.8%) |
| Sep 2020 | - | $159.90 K(-131.4%) | -$601.30 K(-13.6%) |
| Jun 2020 | - | -$509.90 K(-339.3%) | -$696.30 K(+681.5%) |
| Mar 2020 | - | $213.10 K(-145.9%) | -$89.10 K(-34.7%) |
| Dec 2019 | -$136.50 K(-305.0%) | -$464.40 K(-815.6%) | -$136.40 K(-186.6%) |
| Sep 2019 | - | $64.90 K(-33.3%) | $157.50 K(-21.1%) |
| Jun 2019 | - | $97.30 K(-41.3%) | $199.50 K(+49.3%) |
| Mar 2019 | - | $165.80 K(-197.2%) | $133.60 K(+100.9%) |
| Dec 2018 | $66.60 K(-85.1%) | -$170.50 K(-259.5%) | $66.50 K(-83.3%) |
| Sep 2018 | - | $106.90 K(+240.4%) | $397.20 K(-0.1%) |
| Jun 2018 | - | $31.40 K(-68.2%) | $397.40 K(-1.5%) |
| Mar 2018 | - | $98.70 K(-38.4%) | $403.30 K(-9.6%) |
| Dec 2017 | $446.00 K | $160.20 K(+49.6%) | $446.00 K(+75.0%) |
| Sep 2017 | - | $107.10 K(+187.1%) | $254.80 K(-361.3%) |
| Jun 2017 | - | $37.30 K(-73.6%) | -$97.50 K(-87.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $141.40 K(-556.1%) | -$750.00 K(-26.6%) |
| Dec 2016 | -$1.02 M(+666.4%) | -$31.00 K(-87.4%) | -$1.02 M(+75.5%) |
| Sep 2016 | - | -$245.20 K(-60.1%) | -$582.10 K(+41.3%) |
| Jun 2016 | - | -$615.20 K(+372.1%) | -$412.10 K(-331.6%) |
| Mar 2016 | - | -$130.30 K(-131.9%) | $177.90 K(-233.5%) |
| Dec 2015 | -$133.30 K(-93.3%) | $408.60 K(-643.4%) | -$133.30 K(-86.4%) |
| Sep 2015 | - | -$75.20 K(+198.4%) | -$977.80 K(-21.9%) |
| Jun 2015 | - | -$25.20 K(-94.3%) | -$1.25 M(-17.9%) |
| Mar 2015 | - | -$441.50 K(+1.3%) | -$1.52 M(-23.9%) |
| Dec 2014 | -$2.00 M(-3.7%) | -$435.90 K(+25.0%) | -$2.00 M(-33.2%) |
| Sep 2014 | - | -$348.60 K(+16.7%) | -$3.00 M(+2.3%) |
| Jun 2014 | - | -$298.80 K(-67.5%) | -$2.93 M(+4.1%) |
| Mar 2014 | - | -$919.70 K(-35.8%) | -$2.82 M(+48.5%) |
| Dec 2013 | -$2.08 M(-92.7%) | -$1.43 M(+408.0%) | -$1.90 M(+307.4%) |
| Sep 2013 | - | -$281.90 K(+53.3%) | -$465.80 K(+153.3%) |
| Jun 2013 | - | -$183.90 K(+3986.7%) | -$183.90 K(-99.4%) |
| Sep 2009 | - | -$4500.00(+73.1%) | -$28.51 M(+0.0%) |
| Jun 2009 | - | -$2600.00(-86.2%) | -$28.50 M(-0.0%) |
| Mar 2009 | - | -$18.90 K(-99.9%) | -$28.51 M(+0.0%) |
| Dec 2008 | -$28.50 M(>+9900.0%) | -$28.48 M(>+9900.0%) | -$28.50 M(>+9900.0%) |
| Sep 2008 | - | -$4000.00(-38.5%) | -$26.20 K(-11.2%) |
| Jun 2008 | - | -$6500.00(-8.5%) | -$29.50 K(-15.0%) |
| Mar 2008 | - | -$7100.00(-17.4%) | -$34.70 K(+23.0%) |
| Dec 2007 | -$28.20 K(+224.1%) | -$8600.00(+17.8%) | -$28.20 K(+23.7%) |
| Sep 2007 | - | -$7300.00(-37.6%) | -$22.80 K(+33.3%) |
| Jun 2007 | - | -$11.70 K(+1850.0%) | -$17.10 K(+83.9%) |
| Mar 2007 | - | -$600.00(-81.3%) | -$9300.00(+6.9%) |
| Dec 2006 | -$8700.00 | -$3200.00(+100.0%) | -$8700.00(+58.2%) |
| Sep 2006 | - | -$1600.00(-59.0%) | -$5500.00(+41.0%) |
| Jun 2006 | - | -$3900.00 | -$3900.00 |
FAQ
- What is TRxADE HEALTH annual EBITDA?
- What is the all time high annual EBITDA for TRxADE HEALTH?
- What is TRxADE HEALTH annual EBITDA year-on-year change?
- What is TRxADE HEALTH quarterly EBITDA?
- What is the all time high quarterly EBITDA for TRxADE HEALTH?
- What is TRxADE HEALTH quarterly EBITDA year-on-year change?
- What is TRxADE HEALTH TTM EBITDA?
- What is the all time high TTM EBITDA for TRxADE HEALTH?
- What is TRxADE HEALTH TTM EBITDA year-on-year change?
What is TRxADE HEALTH annual EBITDA?
The current annual EBITDA of MEDS is -$11.47 M
What is the all time high annual EBITDA for TRxADE HEALTH?
TRxADE HEALTH all-time high annual EBITDA is $446.00 K
What is TRxADE HEALTH annual EBITDA year-on-year change?
Over the past year, MEDS annual EBITDA has changed by -$9.60 M (-512.68%)
What is TRxADE HEALTH quarterly EBITDA?
The current quarterly EBITDA of MEDS is -$3.45 M
What is the all time high quarterly EBITDA for TRxADE HEALTH?
TRxADE HEALTH all-time high quarterly EBITDA is $408.60 K
What is TRxADE HEALTH quarterly EBITDA year-on-year change?
Over the past year, MEDS quarterly EBITDA has changed by +$3.08 M (+47.23%)
What is TRxADE HEALTH TTM EBITDA?
The current TTM EBITDA of MEDS is -$21.88 M
What is the all time high TTM EBITDA for TRxADE HEALTH?
TRxADE HEALTH all-time high TTM EBITDA is $446.00 K
What is TRxADE HEALTH TTM EBITDA year-on-year change?
Over the past year, MEDS TTM EBITDA has changed by -$3.37 M (-18.21%)